Anti‑metastatic effect of Smilax china L. extract on MDA‑MB‑231 cells

Nho,Kyoung  Jin; Chun,Jin  Mi; Kim,Ho  Kyoung

doi:10.3892/mmr.2014.2698

Anti‑metastatic effect of Smilax china L. extract on MDA‑MB‑231 cells

Authors:
- Kyoung Jin Nho
- Jin Mi Chun
- Ho Kyoung Kim
View Affiliations

Affiliations: Herbal Medicine Resources Group, Korea Institute of Oriental Medicine, Daejeon 305‑811, Republic of Korea
Published online on: October 17, 2014 https://doi.org/10.3892/mmr.2014.2698
Pages: 499-502

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cancer metastases are not always cured by chemotherapy. Conventional and alternative drugs, including Chinese herbal remedies, have been developed to target metastatic cancer cells. Smilax china L. (SCL), a member of the Smilacaceae family, exerts anti‑inflammatory, detoxification and anti‑cancer effects. However, the effect of SCL on breast cancer cell metastasis and the underlying mechanisms are yet to be elucidated. The aim of this study was to investigate the effect of a SCL ethanol extract (SCLE) on the proliferation and migration of MDA‑MB‑231 human breast cancer cells, as well as the expression of urokinase plasminogen activator (uPA), uPA receptor (uPAR) and tissue inhibitors of metalloproteinases (TIMPs). Cell proliferation was assessed using the Cell Counting Kit‑8 and cell migration was determined by wound healing assay. Quantitative polymerase chain reaction was performed to quantify the mRNA levels of uPA, uPAR and TIMPs. SCLE markedly inhibited the proliferation and migration of MDA‑MB‑231 cells, and reduced the mRNA levels of the extracellular matrix (ECM) degradation‑associated molecules uPA, uPAR. By contrast, SCLE significantly increased the mRNA levels of TIMP1 and TIMP2. These findings show that SCLE exerts an anti‑metastatic effect on human breast cancer cells, which may involve the modulation of ECM degradation.

View Figures

View References

1	Kundu N, Campbell P, Hampton B, Lin CY, Ma X, Ambulos N, Zhao XF, Goloubeva O, Holt D and Fulton AM: Antimetastatic activity isolated from Colocasia esculenta (taro). Anti-cancer Drugs. 23:200–211. 2012. View Article : Google Scholar
2	Song G, Ohashi T, Sakamoto N and Sato M: Adhesive force of human hepatoma HepG2 cells to endothelial cells and expression of E-selectin. Mol Cell Biomech. 3:61–68. 2006.PubMed/NCBI
3	Weber GF: Molecular mechanisms of metastasis. Cancer Lett. 270:181–190. 2008. View Article : Google Scholar
4	Festuccia C, Bologna M, Gravina GL, Guerra F, Angelucci A, Villanova I, Millimaggi D and Teti A: Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components. Int J Cancer. 81:395–403. 1999. View Article : Google Scholar
5	Festuccia C, Guerra F, D’Ascenzo S, Giunciuglio D, Albini A and Bologna M: In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int J Cancer. 75:418–431. 1998. View Article : Google Scholar : PubMed/NCBI
6	Hu H, Ahn NS, Yang X, Lee YS and Kang KS: Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer. 102:250–253. 2002. View Article : Google Scholar
7	Lee SM, Li ML, Tse YC, et al: Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. Life Sci. 71:2267–2277. 2002. View Article : Google Scholar : PubMed/NCBI
8	Cheng YL, Lee SC, Lin SZ, Chang WL, Chen YL, Tsai NM, Liu YC, Tzao C, Yu DS and Harn HJ: Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo. Cancer Lett. 222:183–193. 2005.PubMed/NCBI
9	Wang XF, Du J, Zhang TL, Zhou QM, Lu YY, Zhang H and Su SB: Inhibitory effects of PC-SPESII herbal extract on human breast cancer metastasis. Evid Based Complement Alternat Med. 2013:8943862013.PubMed/NCBI
10	Shimizu T, Torres MP, Chakraborty S, Souchek JJ, Rachagani S, Kaur S, Macha M, Ganti AK, Hauke RJ and Batra SK: Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy. Cancer Lett. 336:270–280. 2013. View Article : Google Scholar : PubMed/NCBI
11	Health Department and National Chinese Medicine Management Office. State Administration of Traditional Chinese Medicine of People’s Republic of China. Zhong-hua-ben-cao, Shanghai Science and Technology Publisher; Shanghai, China: pp. 157–160. 1999
12	Li YL, Gan GP, Zhang HZ, Wu HZ, Li CL, Huang YP, Liu YW and Liu JW: A flavonoid glycoside isolated from Smilax china L. rhizome in vitro anticancer effects on human cancer cell lines. J Ethnopharmacol. 113:115–124. 2007.
13	Shu XS, Gao ZH and Yang XL: Anti-inflammatory and anti-nociceptive activities of Smilax china L. aqueous extract. J Ethnopharmacol. 103:327–332. 2006. View Article : Google Scholar
14	Koressaar T and Remm M: Enhancements and modifications of primer design program Primer3. Bioinformatics. 23:1289–1291. 2007. View Article : Google Scholar : PubMed/NCBI
15	Kim MS, You MK, Rhuy DY, Kim YJ, Baek HY and Kim HA: Loquat (Eriobotrya japonica) extracts suppress the adhesion, migration and invasion of human breast cancer cell line. Nutr Res Pract. 3:259–264. 2009.
16	Bogenrieder T and Herlyn M: Axis of evil: molecular mechanisms of cancer metastasis. Oncogene. 22:6524–6536. 2003. View Article : Google Scholar : PubMed/NCBI
17	Du J, Wang XF, Zhou QM, Zhang TL, Lu YY, Zhang H and Su SB: Evodiamine induces apoptosis and inhibits metastasis in MDA-MB-231 human breast cancer cells in vitro and in vivo. Oncol Rep. 30:685–694. 2013.PubMed/NCBI
18	Andres SA, Edwards AB and Wittliff JL: Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance. J Clin Lab Anal. 26:93–103. 2012. View Article : Google Scholar : PubMed/NCBI
19	Dan K, Behrendt N, Brunner N, Ellis V, Ploug M and Pyke C: The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis. 8(Suppl 1): 189–203. 1994. View Article : Google Scholar
20	Brinckerhoff CE and Matrisian LM: Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol. 3:207–214. 2002. View Article : Google Scholar : PubMed/NCBI
21	Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID and Sogayar MC: Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer. 9:202009. View Article : Google Scholar
22	Liotta LA and Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 51(18 Suppl): 5054s–5059s. 1991.PubMed/NCBI
23	Albini A, Melchiori A, Santi L, Liotta LA, Brown PD and Stetler-Stevenson WG: Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst. 83:775–779. 1991. View Article : Google Scholar : PubMed/NCBI